KMX vs LBRX · P/E 19, rev $25.88B vs $803.4M cap
CarMax Inc (KMX) versus LB Pharmaceuticals Inc Common Stock (LBRX) — a side-by-side from cached financials, not a winner call.
CarMax Inc (KMX) is a auto & truck dealerships company listed on US.
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company listed on NASDAQ.
Latest reported KMX revenue for 2026-02-28 was $25.88B. Net income was $247.3M. Revenue was down 1.8% from 2025-02-28 to 2026-02-28. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
LBRX does not have a complete income-statement cache yet.
KMX currently screens at market cap $10.26B and trailing P/E 18.9. LBRX currently screens at market cap $803.4M.
Not investment advice. Open the KMX and LBRX stock pages for the full models.
Not investment advice.